Drug
Tin mesoporphyrin clinical trials
Also written Stannsoporfin.
- studies test it
- 10
- open now
- 0
- in phase 3
- 1
- first study started
- 1993
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 1998 (2)
| Year | Studies |
|---|---|
| 1993 | 1 |
| 1997 | 1 |
| 1998 | 2 |
| 1999 | 2 |
| 2002 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 7
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 6
InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company (4) · National Center for Research Resources (NCRR) (4) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses tin mesoporphyrin is read from its arms, and is right about nine times in ten.
Testing it · 10
- Stannsoporfin With Light Therapy for Newborn Babies With JaundiceCompletedPhase 2InfaCare Pharmaceuticals Corporation, a Mallinckrodt CompanyNCT01887327Written as Stannsoporfin
- A Safety and Efficacy Trial of Stannsoporfin in Neonates With HyperbilirubinemiaTerminatedPhase 2InfaCare Pharmaceuticals Corporation, a Mallinckrodt CompanyNCT00850993Written as Stannsoporfin
- Efficacy and Safety of Stannsoporfin in NeonatesCompletedPhase 3InfaCare Pharmaceuticals Corporation, a Mallinckrodt CompanyNCT02685137Written as stannsoporfin
- Safety and Pharmacology of StanateCompletedPhase 2InfaCare Pharmaceuticals Corporation, a Mallinckrodt CompanyNCT00115544Written as Stanate
- Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature NewbornsCompletedPhase 2Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NCT00004382Written as tin mesoporphyrin
- Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute PorphyriaCompletedPhase 1/2National Center for Research Resources (NCRR)NCT00004789Written as tin mesoporphyrin
- Phase II Randomized Study of Tin Mesoporphyrin for Neonatal HyperbilirubinemiaCompletedPhase 2Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NCT00004381Written as tin mesoporphyrin
- Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute PorphyriasCompletedPhase 2National Center for Research Resources (NCRR)NCT00004396Written as tin mesoporphyrin
- Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of PorphyriaCompletedPhase 1National Center for Research Resources (NCRR)NCT00004397Written as tin mesoporphyrin
- Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of PorphyriaCompletedPhase 1National Center for Research Resources (NCRR)NCT00004398Written as tin mesoporphyrin
Codes
What other systems call tin mesoporphyrin · ClinicalTrials.gg INT003370
- MeSH (NLM) C055421tin mesoporphyrinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 0KAE1U0G7QSTANNSOPORFINConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C055421 | tin mesoporphyrin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 0KAE1U0G7Q | STANNSOPORFIN | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.